Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncology Letters|February 20, 2018
<i>Brucea javanica</i> seed oil enhances the radiosensitivity of esophageal cancer by inhibiting hypoxia-inducible factor 1α, <i>in vitro</i> and <i>in vivo</i>Peng Pan, Bai-Xia Yang, Xiao-Lin Ge
Diagnostic and Interventional Radiology (Ankara, Turkey)|August 10, 2018
Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapyNa-Na Sun, Chang Liu, Xiao-Lin Ge, et al.
La Radiologia Medica|October 13, 2019
Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinomaNa-Na Sun, Xiao-Lin Ge, Xi-Sheng Liu, et al.
Acta Crystallographica. Section E, Structure Reports Online|June 1, 2013
2,4-Dimeth-oxy-6-[(E)-2-(4-meth-oxy-phenyl)ethen-yl]benzaldehydeXiao-Lin Ge, Qiu-Xiang Guan, Sheng-Song Deng, et al.
Frontiers in Oncology|April 5, 2021
Outcomes and Prognostic Factors of Salvage Radiation for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell CarcinomaChi Zhang, Xiao-Lin Ge, Chen-Jun Huang, et al.
Cancer Management and Research|April 21, 2021
Prognostic Factors for Patients with Esophageal Cancer Receiving Definitive Radiotherapy Alone: A Retrospective AnalysisNan Jiang, Xiao-Lin Ge, Zhao-Yue Zhang, et al.
Annals of Translational Medicine|September 3, 2019
Concurrent liposomal paclitaxel and cisplatin chemotherapy improved outcomes for locally advanced esophageal squamous cell carcinoma treated with intensity-modulated radiotherapyShu Liu, Sheng-Nan Ren, Wen-Xiu Ding, et al.
Annals of Translational Medicine|April 11, 2022
Peritoneal dialysis effluent-derived exosomal miR-432-5p: an assessment tool for peritoneal dialysis efficacyYan Tong, Jun-Yan Fang, A-Hui Song, et al.
Translational Lung Cancer Research|June 24, 2021
M<sup>5</sup>C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinomaHui Chen, Xiao-Lin Ge, Zhao-Yue Zhang, et al.
Chinese Medical Journal|May 6, 2011
Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cellsYuan-Dong Cao, Pei-Lin Huang, Xin-Chen Sun, et al.
Pageof 2